Skip to main content

Allergic conditions linked to lower Covid-19 infection risk

New research from Queen Mary University of London sheds new light on the risk factors for developing Covid-19.

Published:
Nurse holds swab for coronavirus test.

Nurse holds swab for coronavirus test. Credit: sonreir es gratis/iStock.com

People with allergic conditions such as hay fever, rhinitis, and atopic eczema, may have a lower risk of Covid-19 infection, especially if they also have asthma, finds a large, population-based study of UK adults, published online in the respiratory journal Thorax.

And contrary to the findings of recent studies, older age, male sex, and other underlying conditions aren’t linked to a heightened risk of infection, the research indicates.

But Asian ethnicity, obesity, household overcrowding, socialising indoors with other households, and holding down a people-facing role other than in health and social care are all independently associated with a heightened risk of developing Covid-19, the findings show.

Exploring risk factors

A growing body of evidence suggests that at least some risk factors for developing Covid-19 may differ from those which predispose to severe disease and the need for intensive care, say the researchers.

To explore this further and glean what contribution demographic, socioeconomic, lifestyle, diet, medical treatment and underlying conditions might make to the risk of developing Covid-19, the researchers captured detailed information on potential risk factors for the infection among UK adults between May 2020 and February 2021. 

All participants were asked to provide information on their age, household circumstances, job, lifestyle, weight, height, long-standing medical conditions, medication use, vaccination status, diet and supplement intake when they joined the study and then again in subsequent months. 

Out of 16,081 eligible people, 15,227 completed at least one subsequent monthly follow-up questionnaire 30 days or more after joining the study; and 14,348 completed the final questionnaire on or before 5 February 2021. 

In all, 446 participants (almost three per cent) had at least one episode of confirmed Covid-19 infection, as determined by swab (PCR or lateral flow) test during the study period, and 32 were admitted to hospital.

What did the researchers find out

Certain factors consequently emerged as being independently associated with increased odds of developing Covid-19. The findings include:

  • People of Asian/Asian British ethnicity were more than twice as likely to become infected as their white counterparts. 
  • Household overcrowding; socialising with other households in the preceding week; number of visits to indoor public places; a people-facing role other than in health and social care; and overweight/obesity were all associated with a heightened risk.
  • The greater the number of people sharing a household and the higher the number of visits made to indoor public places, the higher were the odds of becoming infected, the findings showed.
  • Atopic (triggered by allergens) disease, which includes eczema/dermatitis and hay fever/allergic rhinitis, was independently associated with 23 per cent lower odds of developing the infection than it was in those without atopic disease or asthma. And among those who had atopic disease and asthma, the risk was even lower: 38 per cent. This association held true even after factoring in the use of steroid inhalers. 
  • Taking drugs to dampen down the immune system response (immunosuppressants) was also associated with 53 per cent lower odds of Covid-19 infection, although this may reflect greater shielding from infection by these patients, say the researchers.

But age, sex, other medical conditions, diet and supplement use weren’t associated with infection risk.

The researchers conclude: “This large, population-based prospective study shows that there is limited overlap between risk factors for developing Covid-19 versus those for intensive care unit admission and death, as reported in hospitalised cohorts.”

The study was funded by Barts Charity and BREATHE—The Health Data Research Hub for Respiratory Health in partnership with SAIL Databank.

More information

 

 

Back to top